The target discovery here has the potential of sending molecular therapies in a new direction instead of just perhaps treating with insulin, but rather go one step further and “break the tolerance” as the association and targets areas being identified...
Filed under: Medically Related, Technology, Pharma/FDA News, personalized medicine, Genomics, Diabetes, Disease, Scripps, Journal, targets, molucular therapies, mutations, autoimmune disease, MHC